TriSalus Life Sciences, Inc. (TLSIW)

AI-Powered SEC Filing Analysis

Current Report Filed: 2026-04-07

Key Insights

  • TriSalus Life Sciences, Inc. has appointed Dr. Richard Marshall as its new Chief Medical Officer, effective June 29, 2026.
  • Dr. Marshall will receive an annual base salary of $525,000 and a sign-on bonus of $250,000, along with eligibility for an annual bonus of up to 50% of his base salary.
  • The company will grant Dr. Marshall 120,000 stock options and 60,000 restricted stock units, as well as eligibility for annual equity grants under the company's Equity Incentive Plan.
Filing tone (AI): Positive
View Original Filing →

Filings on this page are at least 90 days old. In the app, any new TriSalus Life Sciences, Inc. filing is analysed the moment you open it.

Download on theApp Store Get it onGoogle Play

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.